These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8161367)

  • 21. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTH activity as determined by canine renal cortical adenylate cyclase assay in chronic renal failure.
    Morita M
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):535-9. PubMed ID: 3656711
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
    Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
    Donadio C; Ardini M; Lucchesi A; Donadio E; Cantor T
    Clin Nephrol; 2007 Mar; 67(3):131-9. PubMed ID: 17390737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.
    Galceran T; Martin KJ; Morrissey JJ; Slatopolsky E
    Kidney Int; 1987 Dec; 32(6):801-7. PubMed ID: 3430963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Clin Nephrol; 1986 Jan; 25(1):7-10. PubMed ID: 3754187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A; Rodriguez M; Martinez ME; Torres A; Felsenfeld AJ
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ionized calcium, intact PTH and novel markers of bone turnover in bedridden elderly patients.
    Sorva A; Välimäki M; Risteli J; Risteli L; Elfving S; Takkunen H; Tilvis R
    Eur J Clin Invest; 1994 Dec; 24(12):806-12. PubMed ID: 7705374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cholecalciferol and calcitriol on biochemical bone markers in HIV type 1-infected males: results of a clinical trial.
    Bang UC; Kolte L; Hitz M; Schierbeck LL; Nielsen SD; Benfield T; Jensen JE
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):658-64. PubMed ID: 23199009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease.
    Herberth J; Fahrleitner-Pammer A; Obermayer-Pietsch B; Krisper P; Holzer H; Malluche HH; Dobnig H
    Clin Nephrol; 2006 May; 65(5):328-34. PubMed ID: 16724653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between a second and a third generation parathyroid hormone assay in hemodialysis patients.
    Gannagé-Yared MH; Farès C; Ibrahim T; Rahal ZA; Elias M; Chelala D
    Metabolism; 2013 Oct; 62(10):1416-22. PubMed ID: 23769129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between frailty and serum N-terminal propeptide of type I procollagen and 25-hydroxyvitamin D in older Spanish women: The Toledo Study for Healthy Aging.
    Alvarez-Ríos AI; Guerrero JM; García-García FJ; Rodríguez-Mañas L; Medrano-Campillo P; de la Torre Lanza MA; Alvarez-Sánchez N; Carrillo-Vico A
    Exp Gerontol; 2015 Sep; 69():79-84. PubMed ID: 26031553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
    Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
    Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrarenal production of calcitriol in normal and uremic humans.
    Dusso AS; Finch J; Brown A; Ritter C; Delmez J; Schreiner G; Slatopolsky E
    J Clin Endocrinol Metab; 1991 Jan; 72(1):157-64. PubMed ID: 1986015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive and negative regulations of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene by parathyroid hormone, calcitonin, and 1alpha,25(OH)2D3 in intact animals.
    Murayama A; Takeyama K; Kitanaka S; Kodera Y; Kawaguchi Y; Hosoya T; Kato S
    Endocrinology; 1999 May; 140(5):2224-31. PubMed ID: 10218975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.